ACHE and Alzheimer disease: In addition, quinoline-sulfonamide hybrids have been developed as potential multifunctional therapeutic agents for AD with high anti-AChE and anti-BChE activity; the lead compound in this series was shown to improve hippocampal-dependent working memory in a rat model [70].